Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.
CompletedOBSERVATIONAL
Enrollment
54
Participants
Timeline
Start Date
June 29, 2020
Primary Completion Date
July 29, 2020
Study Completion Date
August 29, 2020
Conditions
Ovarian Neoplasm
Trial Locations (4)
29000
CHIC, Quimper
29200
Clinique Pasteur, Brest
29229
Clinique Pasteur, Brest
29672
CH des pays de Morlaix, Morlaix
All Listed Sponsors
lead
University Hospital, Brest
OTHER
NCT04573933 - Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019. | Biotech Hunter | Biotech Hunter